Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gary Stewart

Orthopaedic Surgery McDonough, GA Medical Doctor

NPI 1164414256 CMS profile 994468

105 Regency Park Dr, McDonough, GA 30253

Open in the dashboard

General payments

$30,012

213 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gary Stewart of McDonough, GA is reported in the CMS Open Payments database as having received $30,012 across 213 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,498 40
2024 General $5,899 18
2023 General $2,487 25
2022 General $1,980 28
2021 General $6,895 36
2020 General $692 11
2019 General $3,561 55

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gary Stewart
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Gary Stewart were reported at $8,498. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Gary Stewart Orthopaedic Surgery median Middle half National median
2019 $3,561 $644 $140–$2,844 $163
2020 $692 $312 $75–$1,860 $114
2021 $6,895 $520 $117–$2,495 $132
2022 $1,980 $598 $128–$2,731 $149
2023 $2,487 $461 $128–$2,264 $160
2024 $5,899 $497 $134–$2,475 $164
2025 $8,498 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Linvatec Corporation $6,053 12 payments
  2. Stryker Corporation $5,230 62 payments
  3. International Life Sciences $4,500 1 payment
  4. United Orthopedics LLC $3,399 7 payments
  5. Novastep Inc. $2,413 9 payments
  6. Arthrex, Inc. $2,407 28 payments
  7. Wright Medical Technology, Inc. $1,609 31 payments
  8. Paragon 28, Inc. $1,176 9 payments
  9. Bioventus LLC $802 24 payments
  10. Zimmer Biomet Holdings, Inc. $663 12 payments
  11. Other $1,760 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,493 182 payments
  2. Consulting Fee $11,000 6 payments
  3. Travel and Lodging $5,119 23 payments
  4. Education $2,400 2 payments
Products named General payments · program years 2019–2025
  1. BIOBRACE 23MM $5,855 10 payments
  2. FRACTURE AND CORRECTION COLAG 2 $5,463 7 payments
  3. COLINK 2 $5,400 6 payments
  4. FLEXBAND $4,500 1 payment
  5. PROSTEP $1,828 12 payments
  6. INFINITY $1,329 11 payments
  7. FUSIONFRAME Ring Lock Circular Fixator $1,275 1 payment
  8. INBONE $1,148 15 payments
  9. PROPHECY $817 9 payments
  10. SALVATION $593 9 payments
  11. Other $8,178 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

391

Median for Orthopedic Surgery: 203

Drug cost

$3,124

Median for Orthopedic Surgery: $1,433

Branded share of claims

11.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 37 $655
Diclofenac Sodium Generic 23 $634
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 46 $453
Ondansetron Hcl Generic 63 $374
Naproxen Generic 41 $276
Meloxicam Generic 104 $224
Gabapentin Generic 18 $208
Ibuprofen Generic 26 $175
Tramadol Hcl Generic 33 $124

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$93,366

Of which drugs: $1,361

Medicare patients

311

Average age 72

Services billed

2,873

209 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 31%
Chronic kidney disease 29%
Ischemic heart disease 25%
Atrial fibrillation 15%
Depression 15%
COPD 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 34 1,640 $170

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

213 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record